1218-69-5: Deferasirox Benzoxazin Impurity
Deferasirox Benzoxazin Impurity (CAS No.: 1218-69-5) or 2-(2-Hydroxyphenyl)-4H-1,3-benzoxazin-4-one is a synthesis intermediate of Deferasirox which is an oral drug iron chelator evaluated for the treatment of transfusional chronic iron overload. The common side effects related to deferasirox treatment are nausea, vomiting, abdominal pain, constipation and diarrhoea and skin rash.
Additional information
| Catalogue No. | VE000081 |
|---|---|
| CAS No. | 1218-69-5 |
| Molecular Formula | C14H9NO3 |
| Molecular Weight | 239.23 g/mol |
| IUPAC Name | 2-(2-Hydroxyphenyl)-4H-1, 3-benzoxazin-4-one |
| References | Stucky, Stefan, et al. “3, 5-Bis(2-Hydroxyphenyl)-1H-1, 2, 4-Triazole Based Ligands — Protonation and Metal Complex Formation.” Chemical Papers, vol. 62, no. 4, Jan. 2008, https://doi.org/10.2478/s11696-008-0043-x.?Yang, Lily P. H., et al. “Deferasirox.” Drugs, vol. 67, no. 15, 2007, pp. 2211–30, https://doi.org/10.2165/00003495-200767150-00007.? |
| Status | In-stock |
